Creative Planning’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Creative Planning’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-56,728	Closed	-$148K	–	2696
2021 Q1	$148K	Buy	56,728 +10,453	+23%	+$29.6K	﹤0.01%	2170
2020 Q4	$129K	Buy	+46,275	New	+$135K	﹤0.01%	1991
2017 Q3	–	Sell	-8	Closed	-$1K	–	3963
2017 Q2	$1K	Buy	+8	New	+$1.4K	﹤0.01%	4538
2017 Q1	–	Sell	-375	Closed	-$37K	–	4976
2016 Q4	$37K	Buy	+375	New	+$39.5K	﹤0.01%	2640
2016 Q3	–	Sell	-38	Closed	-$4.56K	–	4788
2016 Q2	$4K	Hold	38	–	–	﹤0.01%	3797
2016 Q1	$3K	Hold	38	–	–	﹤0.01%	3849
2015 Q4	$5K	Buy	+38	New	+$4.95K	﹤0.01%	3716

Other funds holding SIOX

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

TVWM

Tower View Wealth Management Shorewood, Wisconsin $195M AUM 29.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Creative Planning's SIOX Position: Q2 2021 in Review

Creative Planning sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2021, closing a stake of 56,728 shares — an estimated $148K sold.

Creative Planning first reported a position in SIOX in Q4 2015 and held it in 7 quarters. The position peaked at $148K in Q1 2021. 54 funds tracked by Wall St. Rank hold SIOX as of Q2 2021.

Creative Planning reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Creative Planning sold 56,728 Sio Gene Therapies Inc. Common Stock shares in Q2 2021, an estimated $148K.
Creative Planning first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2015 and held it in 7 quarters.
Creative Planning's Sio Gene Therapies Inc. Common Stock position peaked at $148K in Q1 2021.
54 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2021.

Based on Creative Planning's 13F filing for Q2 2021, filed 4 Aug 2021.